Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

HHS Secretary Xavier Becerra Extends Public Health Emergency

Amanda Grimm Wiegrefe, MScHSRA  |  April 16, 2021

On Jan. 31, 2020, then Department of Health & Human Services (HHS) Secretary Alex Azar issued the first public health emergency (PHE) in response to the emerging coronavirus pandemic. The PHE declaration triggered significant steps from the federal government to ramp up efforts to reduce the spread of the virus, as well as new flexibilities to help providers continue to care for their patients during a pandemic. The PHE declaration lasts 90 days and has been extended five times since January 2020. On April 15, Xavier Becerra, the newly confirmed HHS secretary, renewed the extension, effective April 21, 2021.

The Biden administration has said that its number one policy priority is addressing the coronavirus pandemic through greater vaccine production, distribution and education. The administration has indicated that the PHE will likely be extended through the end of the year.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Flexibilities Under the PHE
Following the first PHE declaration, many federal agencies issued new rules and policies that allowed for greater flexibilities to try to “flatten the curve” of increasing coronavirus cases.

The Centers for Medicare & Medicaid Services (CMS), recognizing the need for expanding telehealth during the pandemic, issued several telehealth-related flexibilities and waivers. In particular, it waived a number of requirements, including site-of-service requirements, issued flexibilities allowing providers to provide services across state lines and allowed providers to use everyday technology (such as Zoom) for telehealth visits. Following significant advocacy from many medical associations, including the ACR, CMS also reimagined reimbursement for telehealth visits during the pandemic. Under the PHE, audio-visual and audio-only telehealth visits are reimbursed at the same rate as an in-office visit.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Although these flexibilities will end when the PHE is rescinded, CMS recognizes that telehealth is here to stay. In the CY2021 Medicare Physician Fee Schedule, CMS outlined additions to the telehealth services list and the expanded use of virtual check-ins to allow for some audio-only telehealth visits. These new services will help expand the use of telehealth but will do so at lower reimbursement levels than the PHE reimbursement levels.

The ACR is actively engaged in advocacy efforts to expand the use and reimbursement of telehealth services beyond the current PHE and has many telehealth resources for providers.


Amanda Grimm Wiegrefe, MScHSRA, is the ACR’s director of regulatory affairs.

Share: 

Filed under:From the CollegeLegislation & Advocacy Tagged with:COVID-19U.S. public health emergency

Related Articles

    What’s Next for Telehealth after the COVID-19 Public Health Emergency?

    June 10, 2023

    Do you remember where you were when the COVID-19 Public Health Emergency (PHE) was declared on Jan. 31, 2020? While it may seem like yesterday, you would be forgiven for not recalling your exact location over three years ago during what felt like an incredible whirlwind for the healthcare industry. One possible location you may…

    Charting a New Course Post-PHE

    May 23, 2023

    The public health emergency (PHE), in place since 2020, officially expired at midnight on May 11. The PHE declaration allowed significant flexibility in the healthcare system. The end of the PHE impacts several policies, including changes in Medicare and Medicaid policies. What do these changes mean for providers?

    The Pandemic’s End: What Do the Ending National Emergency Proclamations Mean for Healthcare?

    April 21, 2023

    As COVID-19 case counts fade from the headlines and people return to their pre-pandemic routines, rheumatologists and rheumatology professionals may be wondering what “the end” of COVID-19 is going to look like for them. Much of that answer lies in the status of the federal emergencies that have been declared in response to COVID-19. These…

    Telerheumatology: What’s Next?

    December 17, 2020

    In an ACR Convergence session, two rheumatologists discussed how COVID-19 changed the use of telemedicine, how payers reacted and which changes are likely permanent and which are likely to be temporary.

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences